| Title of Invention | A SUBSTITUTED LACTAM COMPOUND AND PHARMACEUTICAL COMPOSITION THEREOF |
|---|---|
| Abstract | The present invention provides the compound of formula (I), (N)-((S)-2-hydroxy-3-methyl-butyryl)-1-(L-alaninyl)-(S)-1-amino-3-methyl-2,3,4,5-tetrahydro-2H-3-benzazepin-2 one, compositions thereof, and methods for using the same. |
| Full Text |
|---|
609-KOLNP-2003-CORRESPONDENCE.pdf
609-kolnp-2003-granted-abstract.pdf
609-kolnp-2003-granted-claims.pdf
609-kolnp-2003-granted-correspondence.pdf
609-kolnp-2003-granted-description (complete).pdf
609-kolnp-2003-granted-examination report.pdf
609-kolnp-2003-granted-form 1.pdf
609-kolnp-2003-granted-form 13.pdf
609-kolnp-2003-granted-form 18.pdf
609-kolnp-2003-granted-form 2.pdf
609-kolnp-2003-granted-form 26.pdf
609-kolnp-2003-granted-form 3.pdf
609-kolnp-2003-granted-form 5.pdf
609-kolnp-2003-granted-gpa.pdf
609-kolnp-2003-granted-letter patent.pdf
609-kolnp-2003-granted-reply to examination report.pdf
609-kolnp-2003-granted-specification.pdf
609-kolnp-2003-granted-translated copy of priority document.pdf
| Patent Number | 220487 | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Indian Patent Application Number | 609/KOLNP/2003 | ||||||||||||||||||||||||
| PG Journal Number | 22/2008 | ||||||||||||||||||||||||
| Publication Date | 30-May-2008 | ||||||||||||||||||||||||
| Grant Date | 28-May-2008 | ||||||||||||||||||||||||
| Date of Filing | 13-May-2003 | ||||||||||||||||||||||||
| Name of Patentee | ELI LILLY AND COMPANY | ||||||||||||||||||||||||
| Applicant Address | LILLY CORPORATE CENTER, DROP CODE 1104, INDIANAPOLIS, IN 46285 | ||||||||||||||||||||||||
Inventors:
|
|||||||||||||||||||||||||
| PCT International Classification Number | A61K 31/00 | ||||||||||||||||||||||||
| PCT International Application Number | PCT/US2001/27799 | ||||||||||||||||||||||||
| PCT International Filing date | 2001-11-05 | ||||||||||||||||||||||||
PCT Conventions:
|
|||||||||||||||||||||||||